Document is current

Article History

Received: 4 October 2024

Accepted: 27 November 2024

First Online: 11 December 2024

Declarations

:

: Maria A. Aleshin has served as a consultant for AbbVie, Santa Ana Bio, and Mirador, as an advisory board member for Novartis, and has received research funding from UCB. Heather M. Holahan is a speaker for Novartis. Vivian Y. Shi is on the board of directors for the Hidradenitis Suppurativa Foundation (HSF), an advisor for the National Eczema Association, is a stock shareholder of Learn Health and has served as an advisory board member, investigator, speaker, and/or received research funding from Sanofi Genzyme, Regeneron, AbbVie, Genentech, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Pfizer, Incyte, Dermavant, Boehringer Ingelheim, Almirall, Alumis, Aristea Therapeutics, Menlo Therapeutics, Dermira, Burt’s Bees, Galderma, Kiniksa, UCB, Ceraclere, Bain Capital, Target-PharmaSolutions, Castle Bioscience, Altus Lab/cQuell, MYOR, Polyfins Technology, GpSkin and Skin Actives Scientific. Vivian Y. Shi is currently affiliated with the Department of Dermatology, University of Washington, Seattle, Washington, USA. Jennifer L. Hsiao is on the Board of Directors for the Hidradenitis Suppurativa Foundation, has served as a consultant for AbbVie, Aclaris, Boehringer Ingelheim, Incyte, Novartis, and UCB; as a speaker for AbbVie, Novartis, UCB; as an investigator for Amgen, Boehringer Ingelheim, and Incyte. Jennifer L. Hsiao is an editorial board member of Dermatology and Therapy. Jennifer L. Hsiao was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Sarah E. Park has nothing to disclose. Elaine Ma has nothing to disclose. Caitlyn Dagenet has nothing to disclose.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.